Articles

A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency

Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest,Assistance Publique;
Cancer Research Center of Toulouse, CRCT, UMR1037, Paul Sabatier-University, Toulouse, France;
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest,Assistance Publique;
Cancerology research center Marseille, CRCM, Aix Marseille University, Institut Paoli-Calmettes, CNR;
Cancer Research Center of Toulouse, CRCT, UMR1037, Paul Sabatier-University, Toulouse, France;
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest,Assistance Publique;
Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France;
Dept. of Pediatric Immunology,Hematology and Rheumatology,Necker-Enfants Malades University Hospital;
Dept. of Pediatric Immunology,Hematology and Rheumatology,Necker-Enfants Malades University Hospital;
Cancerology research center Marseille, CRCM, Aix Marseille University, Institut Paoli-Calmettes, CNR;
Study Center for Primary Immunodeficiencies, Assistance Publique, Hopitaux de Paris (AP-HP);
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller University, New York
Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France;
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest,Assistance Publique;
Haematologica Early view Jan 9, 2020 https://doi.org/10.3324/haematol.2019.230250